Érick Moyneur

2.5k total citations
43 papers, 1.2k citations indexed

About

Érick Moyneur is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Érick Moyneur has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Epidemiology. Recurrent topics in Érick Moyneur's work include Menopause: Health Impacts and Treatments (11 papers), Hormonal and reproductive studies (6 papers) and Estrogen and related hormone effects (6 papers). Érick Moyneur is often cited by papers focused on Menopause: Health Impacts and Treatments (11 papers), Hormonal and reproductive studies (6 papers) and Estrogen and related hormone effects (6 papers). Érick Moyneur collaborates with scholars based in United States, Canada and Switzerland. Érick Moyneur's co-authors include Victoria Barghout, Arun J. Sanyal, Andrew Poklepovic, Mei Sheng Duh, Simone Peart Boyce, Fernand Labrie, John Balser, Lyne Lavoie, David F. Archer and Céline Martel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Érick Moyneur

41 papers receiving 1.1k citations

Peers

Érick Moyneur

EDM

GENET

ONCOL

EPIDE

PFM

Joel T. Adler United States

Carolyn Neville Canada

Michael Steinbuch United States

Nancy L. Cho United States

Ágnes Benedict United States

Ezzeldin M. Ibrahim Saudi Arabia

Hiroto Narimatsu Japan

Andreas Brandt Germany

Medha Barbhaiya United States

Joel T. Adler United States

Érick Moyneur

470 ×0.9

EDM

114 ×0.4

GENET

200 ×0.8

ONCOL

172 ×0.7

EPIDE

101 ×0.6

PFM

Citations per year, relative to Érick Moyneur Érick Moyneur (= 1×) peers Joel T. Adler

Countries citing papers authored by Érick Moyneur

Since Specialization

Citations

This map shows the geographic impact of Érick Moyneur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Érick Moyneur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Érick Moyneur more than expected).

Fields of papers citing papers by Érick Moyneur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Érick Moyneur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Érick Moyneur. The network helps show where Érick Moyneur may publish in the future.

Co-authorship network of co-authors of Érick Moyneur

This figure shows the co-authorship network connecting the top 25 collaborators of Érick Moyneur. A scholar is included among the top collaborators of Érick Moyneur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Érick Moyneur. Érick Moyneur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rubin, Rachel, et al.. (2025). Prevalence of urinary tract infections in women with vulvovaginal atrophy and the impact of vaginal prasterone on the rate of urinary tract infections. Menopause The Journal of The North American Menopause Society. 32(3). 217–227. 1 indexed citations

Townsend, Raymond R., et al.. (2025). Risk of Hypertension and Chronic Kidney Disease Following Aldosterone Dysregulation. American Journal of Hypertension. 39(1). 161–170. 1 indexed citations

Horgan, Casie, Efe Eworuke, Jennifer G. Lyons, et al.. (2024). Identifying pediatric hypertension in observational data: comparing clinical and claims cohorts in real-world data. American Journal of Epidemiology. 194(2). 407–419. 1 indexed citations

Pawloski, Pamala A., Cara L. McDermott, Gabriela Vazquez‐Benitez, et al.. (2023). Abstract P4-03-33: A Population-based Analysis of Prophylactic G-CSF Biosimilar and Originator Administration over time among Patients Diagnosed with Breast Cancer. Cancer Research. 83(5_Supplement). P4–3. 1 indexed citations

Moyneur, Érick, Katherine Dea, Leonard R. Derogatis, et al.. (2019). Prevalence of depression and anxiety in women newly diagnosed with vulvovaginal atrophy and dyspareunia. Menopause The Journal of The North American Menopause Society. 27(2). 134–142. 18 indexed citations

Labrie, Fernand, David F. Archer, William Koltun, et al.. (2018). Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause The Journal of The North American Menopause Society. 25(11). 1339–1353. 68 indexed citations

Toh, Sengwee, Robert Wellman, R. Yates Coley, et al.. (2018). Combining distributed regression and propensity scores: a doubly privacy-protecting analytic method for multicenter research. Clinical Epidemiology. Volume 10. 1773–1786. 14 indexed citations

Moyneur, Érick, et al.. (2017). Very Low Compliance for Vulvovaginal Atrophy (VVA) Treatment: A Retrospective U.S. Healthcare Claims Database Analysis. Value in Health. 20(9). A525–A525. 1 indexed citations

Labrie, Fernand, David F. Archer, William Koltun, et al.. (2016). Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause The Journal of The North American Menopause Society. 23(3). 243–256. 168 indexed citations

10.

Martel, Céline, Fernand Labrie, David F. Archer, et al.. (2016). Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5 mg intravaginal prasterone for 12 weeks. The Journal of Steroid Biochemistry and Molecular Biology. 159. 142–153. 51 indexed citations

11.

Bouchard, Céline, Fernand Labrie, Leonard R. Derogatis, et al.. (2015). Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study. Hormone Molecular Biology and Clinical Investigation. 25(3). 181–190. 34 indexed citations

12.

Labrie, Fernand, Leonard R. Derogatis, David F. Archer, et al.. (2015). Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy. The Journal of Sexual Medicine. 12(12). 2401–2412. 69 indexed citations

13.

Montesino, Marlene, Fernand Labrie, David F. Archer, et al.. (2015). Evaluation of the acceptability of intravaginal prasterone ovule administration using an applicator. Gynecological Endocrinology. 32(3). 240–245. 7 indexed citations

14.

Ke, Yuyong, Fernand Labrie, Renaud Gonthier, et al.. (2015). Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration. The Journal of Steroid Biochemistry and Molecular Biology. 154. 186–196. 24 indexed citations

15.

Labrie, Fernand, David F. Archer, Céline Bouchard, et al.. (2015). Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. Maturitas. 81(1). 46–56. 44 indexed citations

16.

Butrynski, James E., et al.. (2008). Soft tissue sarcoma (STS): Challenges in identification, treatment patterns, and costs of disease management in the U.S.. Journal of Clinical Oncology. 26(15_suppl). 10573–10573. 1 indexed citations

17.

Moyneur, Érick, Brahim Bookhart, Samir H. Mody, et al.. (2008). The Economic Impact of Pre-Dialysis Epoetin Alfa on Health Care and Work Loss Costs in Chronic Kidney Disease: An Employer's Perspective. Disease Management. 11(1). 49–58. 7 indexed citations

18.

Mincey, Betty A., Mei Sheng Duh, Simu K. Thomas, et al.. (2006). Risk of Cancer Treatment—Associated Bone Loss and Fractures Among Women with Breast Cancer Receiving Aromatase Inhibitors. Clinical Breast Cancer. 7(2). 127–132. 72 indexed citations

19.

Smith, Matthew R., Simone Peart Boyce, Érick Moyneur, et al.. (2005). Risk of Clinical Fractures After Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer. The Journal of Urology. 175(1). 136–139. 150 indexed citations

20.

Baker, Laurence C., et al.. (2003). The Relationship Between Technology Availability And Health Care Spending. Health Affairs. 22(Suppl1). W3–537. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact